Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Transplantation, Heterologous | 24 | 2004 | 2379 | 1.430 |
Why?
|
Graft Rejection | 51 | 2011 | 4426 | 1.180 |
Why?
|
Tracheostomy | 2 | 2021 | 425 | 1.100 |
Why?
|
Skin Transplantation | 27 | 2011 | 1083 | 1.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 7 | 2024 | 5251 | 0.970 |
Why?
|
Transplantation Immunology | 10 | 2004 | 532 | 0.840 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2023 | 167 | 0.750 |
Why?
|
Pericardial Effusion | 1 | 2023 | 247 | 0.750 |
Why?
|
Lung Neoplasms | 8 | 2024 | 13262 | 0.680 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2021 | 97 | 0.650 |
Why?
|
Pleural Neoplasms | 1 | 2023 | 609 | 0.620 |
Why?
|
Histocompatibility Antigens Class II | 16 | 2002 | 1446 | 0.610 |
Why?
|
Radiosurgery | 2 | 2024 | 1343 | 0.580 |
Why?
|
Islets of Langerhans Transplantation | 12 | 2008 | 739 | 0.570 |
Why?
|
Graft Survival | 32 | 2011 | 3794 | 0.560 |
Why?
|
Immune Tolerance | 16 | 2010 | 2299 | 0.550 |
Why?
|
CD4-Positive T-Lymphocytes | 17 | 2005 | 4353 | 0.490 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 9 | 1992 | 899 | 0.480 |
Why?
|
T-Lymphocytes | 23 | 2011 | 10181 | 0.470 |
Why?
|
Tomography, Optical Coherence | 5 | 2024 | 2884 | 0.430 |
Why?
|
Idiopathic Pulmonary Fibrosis | 3 | 2024 | 502 | 0.420 |
Why?
|
Lymphocyte Depletion | 9 | 2004 | 602 | 0.410 |
Why?
|
Allergy and Immunology | 2 | 2011 | 175 | 0.410 |
Why?
|
Vascular Surgical Procedures | 1 | 2021 | 1475 | 0.400 |
Why?
|
Tracheal Diseases | 1 | 2012 | 115 | 0.400 |
Why?
|
Bronchoscopy | 4 | 2024 | 911 | 0.390 |
Why?
|
Thoracic Surgical Procedures | 1 | 2015 | 348 | 0.390 |
Why?
|
Pneumonectomy | 5 | 2024 | 1111 | 0.370 |
Why?
|
Lymphatic Diseases | 1 | 2012 | 319 | 0.370 |
Why?
|
Heart Transplantation | 14 | 2011 | 3224 | 0.370 |
Why?
|
Histocompatibility Antigens Class I | 8 | 1999 | 1355 | 0.360 |
Why?
|
T-Lymphocytes, Helper-Inducer | 7 | 1997 | 975 | 0.360 |
Why?
|
Lymphocyte Activation | 9 | 2011 | 5496 | 0.350 |
Why?
|
Mice, Inbred BALB C | 34 | 2011 | 6216 | 0.340 |
Why?
|
Isoantigens | 6 | 2001 | 552 | 0.330 |
Why?
|
Cell Transplantation | 6 | 2000 | 472 | 0.330 |
Why?
|
Transplantation Tolerance | 3 | 2004 | 605 | 0.310 |
Why?
|
Organ Transplantation | 4 | 1999 | 1150 | 0.300 |
Why?
|
Diabetes Mellitus, Type 1 | 15 | 2008 | 3455 | 0.290 |
Why?
|
Transplantation, Homologous | 19 | 2011 | 4810 | 0.280 |
Why?
|
Trachea | 1 | 2012 | 1082 | 0.280 |
Why?
|
Major Histocompatibility Complex | 6 | 2001 | 928 | 0.270 |
Why?
|
Isoantibodies | 8 | 2006 | 661 | 0.260 |
Why?
|
Genes, MHC Class II | 5 | 2004 | 451 | 0.250 |
Why?
|
Antigen Presentation | 4 | 2004 | 1254 | 0.250 |
Why?
|
Disease Management | 1 | 2015 | 2514 | 0.240 |
Why?
|
Lung Diseases, Interstitial | 2 | 2024 | 911 | 0.240 |
Why?
|
Neurosurgical Procedures | 1 | 2015 | 2056 | 0.240 |
Why?
|
Graft Enhancement, Immunologic | 3 | 2004 | 57 | 0.230 |
Why?
|
Neoplasm Staging | 6 | 2023 | 11152 | 0.230 |
Why?
|
Animals | 91 | 2011 | 167963 | 0.230 |
Why?
|
Antibodies, Monoclonal | 20 | 2005 | 9185 | 0.220 |
Why?
|
Kaplan-Meier Estimate | 2 | 2024 | 6544 | 0.210 |
Why?
|
Immunoconjugates | 3 | 2001 | 949 | 0.210 |
Why?
|
Immunosuppressive Agents | 10 | 2006 | 4166 | 0.210 |
Why?
|
Antigens, Differentiation | 5 | 2005 | 911 | 0.210 |
Why?
|
Antigens, Surface | 4 | 2003 | 1608 | 0.210 |
Why?
|
Cyclosporins | 4 | 1990 | 216 | 0.210 |
Why?
|
Nuclear Transfer Techniques | 1 | 2002 | 61 | 0.200 |
Why?
|
Kidney Transplantation | 18 | 2004 | 4215 | 0.190 |
Why?
|
Mice, Inbred C57BL | 34 | 2007 | 22023 | 0.190 |
Why?
|
Mice | 63 | 2011 | 81208 | 0.190 |
Why?
|
Subclavian Vein | 1 | 2021 | 58 | 0.190 |
Why?
|
Mice, Mutant Strains | 11 | 2005 | 1753 | 0.180 |
Why?
|
T-Lymphocyte Subsets | 5 | 2003 | 1810 | 0.180 |
Why?
|
Antigen-Presenting Cells | 7 | 2001 | 967 | 0.180 |
Why?
|
Subclavian Artery | 1 | 2021 | 134 | 0.180 |
Why?
|
Antilymphocyte Serum | 7 | 2003 | 482 | 0.170 |
Why?
|
Lymphocyte Cooperation | 2 | 1996 | 113 | 0.170 |
Why?
|
CD8-Positive T-Lymphocytes | 10 | 2005 | 4550 | 0.170 |
Why?
|
Dilatation | 1 | 2021 | 307 | 0.170 |
Why?
|
Insurance Coverage | 3 | 2016 | 1939 | 0.170 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2001 | 585 | 0.170 |
Why?
|
Mice, Inbred Strains | 10 | 2002 | 1763 | 0.160 |
Why?
|
Ribs | 1 | 2021 | 252 | 0.160 |
Why?
|
Brachial Plexus | 1 | 2021 | 166 | 0.160 |
Why?
|
Immunity, Cellular | 5 | 1999 | 1557 | 0.160 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2002 | 542 | 0.160 |
Why?
|
Humans | 81 | 2024 | 760621 | 0.160 |
Why?
|
Clavicle | 1 | 2021 | 224 | 0.160 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2023 | 421 | 0.150 |
Why?
|
Histocompatibility Antigens | 5 | 1996 | 467 | 0.150 |
Why?
|
T-Lymphocytes, Cytotoxic | 5 | 2005 | 1765 | 0.150 |
Why?
|
Thorax | 1 | 2021 | 553 | 0.150 |
Why?
|
Autoimmunity | 4 | 2007 | 1370 | 0.150 |
Why?
|
Swine | 14 | 2004 | 5899 | 0.140 |
Why?
|
Genes, MHC Class I | 3 | 1997 | 240 | 0.140 |
Why?
|
Health Care Reform | 3 | 2016 | 1245 | 0.140 |
Why?
|
CD40 Ligand | 5 | 2006 | 521 | 0.130 |
Why?
|
Pancreas Transplantation | 7 | 2003 | 196 | 0.130 |
Why?
|
History, 20th Century | 4 | 2011 | 2773 | 0.130 |
Why?
|
Spleen | 5 | 2004 | 2298 | 0.120 |
Why?
|
Healthcare Disparities | 3 | 2016 | 3388 | 0.120 |
Why?
|
Cholecystitis, Acute | 1 | 2015 | 74 | 0.120 |
Why?
|
Insurance, Health | 3 | 2016 | 2501 | 0.120 |
Why?
|
Host vs Graft Reaction | 1 | 1994 | 13 | 0.120 |
Why?
|
Robotics | 1 | 2022 | 874 | 0.120 |
Why?
|
Bone Marrow Transplantation | 7 | 2001 | 2693 | 0.120 |
Why?
|
Aftercare | 1 | 2020 | 916 | 0.120 |
Why?
|
Mice, Inbred NOD | 8 | 2008 | 1837 | 0.120 |
Why?
|
Antigens, CD | 9 | 2005 | 4000 | 0.120 |
Why?
|
Cytotoxicity, Immunologic | 6 | 1993 | 1351 | 0.110 |
Why?
|
Swine, Miniature | 7 | 2004 | 959 | 0.110 |
Why?
|
Myocytes, Cardiac | 1 | 2002 | 1657 | 0.110 |
Why?
|
Resource Allocation | 2 | 1994 | 349 | 0.110 |
Why?
|
Receptors, Chemokine | 3 | 2006 | 655 | 0.110 |
Why?
|
Radiation Chimera | 3 | 1988 | 216 | 0.110 |
Why?
|
Streptozocin | 2 | 2003 | 194 | 0.110 |
Why?
|
Cholecystectomy | 1 | 2015 | 406 | 0.110 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 2 | 1996 | 303 | 0.110 |
Why?
|
Thymectomy | 5 | 1994 | 194 | 0.110 |
Why?
|
Cyclosporine | 5 | 2004 | 777 | 0.100 |
Why?
|
Thoracic Surgery | 1 | 2019 | 725 | 0.100 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2003 | 1112 | 0.100 |
Why?
|
Tissue Engineering | 1 | 2002 | 1870 | 0.100 |
Why?
|
Islets of Langerhans | 4 | 2008 | 1345 | 0.100 |
Why?
|
Antigens, Heterophile | 1 | 1992 | 70 | 0.100 |
Why?
|
Macaca fascicularis | 6 | 2006 | 900 | 0.090 |
Why?
|
United States Food and Drug Administration | 1 | 1999 | 1677 | 0.090 |
Why?
|
Research | 1 | 1999 | 1974 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2024 | 1864 | 0.090 |
Why?
|
Species Specificity | 8 | 2002 | 2418 | 0.090 |
Why?
|
Liver Transplantation | 5 | 1996 | 2325 | 0.090 |
Why?
|
Tissue Donors | 6 | 2004 | 2313 | 0.080 |
Why?
|
Immunoglobulin Idiotypes | 4 | 1983 | 200 | 0.080 |
Why?
|
NFATC Transcription Factors | 1 | 2011 | 381 | 0.080 |
Why?
|
Models, Immunological | 4 | 2002 | 513 | 0.080 |
Why?
|
Comorbidity | 1 | 2024 | 10551 | 0.080 |
Why?
|
Antibodies | 5 | 2007 | 2421 | 0.080 |
Why?
|
Health Care Rationing | 1 | 1992 | 435 | 0.080 |
Why?
|
Bioethics | 2 | 2000 | 117 | 0.080 |
Why?
|
Mice, Inbred C3H | 5 | 1993 | 915 | 0.080 |
Why?
|
Government Programs | 1 | 2010 | 280 | 0.080 |
Why?
|
Immune System Diseases | 1 | 2010 | 258 | 0.080 |
Why?
|
Ethics, Medical | 3 | 2000 | 783 | 0.080 |
Why?
|
Adoptive Transfer | 4 | 2005 | 822 | 0.080 |
Why?
|
Mice, Inbred A | 4 | 1998 | 246 | 0.080 |
Why?
|
Antibodies, Anti-Idiotypic | 4 | 1983 | 356 | 0.080 |
Why?
|
alpha 1-Antitrypsin | 1 | 2008 | 169 | 0.070 |
Why?
|
Histocompatibility Testing | 5 | 2002 | 717 | 0.070 |
Why?
|
Health Status Disparities | 2 | 2016 | 1830 | 0.070 |
Why?
|
Mice, Knockout | 10 | 2011 | 14372 | 0.070 |
Why?
|
Transplantation | 2 | 2004 | 218 | 0.070 |
Why?
|
Zoonoses | 2 | 2000 | 179 | 0.070 |
Why?
|
Retrospective Studies | 9 | 2024 | 80372 | 0.070 |
Why?
|
Integrin beta3 | 1 | 2007 | 121 | 0.070 |
Why?
|
Primates | 2 | 1999 | 523 | 0.070 |
Why?
|
Autoantigens | 2 | 2002 | 877 | 0.070 |
Why?
|
Crosses, Genetic | 4 | 1995 | 751 | 0.070 |
Why?
|
Th2 Cells | 4 | 2011 | 1047 | 0.070 |
Why?
|
Th1 Cells | 4 | 2011 | 1032 | 0.070 |
Why?
|
Interleukin-2 | 2 | 2007 | 1889 | 0.070 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2016 | 1200 | 0.070 |
Why?
|
Cytokines | 7 | 2007 | 7343 | 0.060 |
Why?
|
Postoperative Complications | 4 | 2024 | 15697 | 0.060 |
Why?
|
Budgets | 1 | 2007 | 230 | 0.060 |
Why?
|
H-2 Antigens | 3 | 1998 | 358 | 0.060 |
Why?
|
Male | 39 | 2024 | 359744 | 0.060 |
Why?
|
Transplantation, Heterotopic | 1 | 2005 | 174 | 0.060 |
Why?
|
Peripheral Arterial Disease | 1 | 2016 | 1306 | 0.060 |
Why?
|
Fetal Tissue Transplantation | 1 | 2004 | 137 | 0.060 |
Why?
|
Massachusetts | 5 | 2019 | 8803 | 0.060 |
Why?
|
Monocyte Chemoattractant Proteins | 1 | 2004 | 47 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2004 | 3075 | 0.060 |
Why?
|
Insulin-Secreting Cells | 2 | 2008 | 907 | 0.060 |
Why?
|
Bone Marrow | 3 | 1993 | 2912 | 0.060 |
Why?
|
B-Lymphocytes | 2 | 1996 | 4742 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2019 | 3620 | 0.060 |
Why?
|
C-Peptide | 4 | 2008 | 433 | 0.050 |
Why?
|
Clinical Competence | 1 | 2019 | 4783 | 0.050 |
Why?
|
beta 2-Microglobulin | 2 | 1995 | 328 | 0.050 |
Why?
|
Immunologic Memory | 3 | 2005 | 1354 | 0.050 |
Why?
|
Prognosis | 1 | 2023 | 29658 | 0.050 |
Why?
|
Cloning, Organism | 1 | 2002 | 50 | 0.050 |
Why?
|
Self Tolerance | 1 | 2002 | 124 | 0.050 |
Why?
|
Rabbits | 6 | 1991 | 4773 | 0.050 |
Why?
|
Female | 37 | 2024 | 391270 | 0.050 |
Why?
|
Cell Adhesion Molecules | 3 | 1993 | 1602 | 0.050 |
Why?
|
Mice, SCID | 2 | 1998 | 2627 | 0.050 |
Why?
|
Mice, Transgenic | 5 | 2007 | 9530 | 0.050 |
Why?
|
Health Services Accessibility | 2 | 2016 | 5397 | 0.050 |
Why?
|
History, 19th Century | 1 | 2004 | 720 | 0.050 |
Why?
|
Down-Regulation | 2 | 2005 | 2913 | 0.050 |
Why?
|
Thymus Gland | 4 | 2001 | 1247 | 0.050 |
Why?
|
Polyglycolic Acid | 1 | 2002 | 405 | 0.050 |
Why?
|
Patient Selection | 2 | 1994 | 4283 | 0.050 |
Why?
|
Lung | 3 | 2024 | 9994 | 0.050 |
Why?
|
Kidney | 6 | 2003 | 7064 | 0.050 |
Why?
|
Tacrolimus | 1 | 2004 | 733 | 0.040 |
Why?
|
Middle Aged | 20 | 2024 | 220352 | 0.040 |
Why?
|
Acute Disease | 6 | 2005 | 7269 | 0.040 |
Why?
|
Receptors, CCR5 | 1 | 2002 | 488 | 0.040 |
Why?
|
Coated Materials, Biocompatible | 1 | 2002 | 318 | 0.040 |
Why?
|
Health Policy | 1 | 1992 | 2677 | 0.040 |
Why?
|
Intraoperative Care | 1 | 2003 | 768 | 0.040 |
Why?
|
Tissue and Organ Procurement | 4 | 1994 | 944 | 0.040 |
Why?
|
Killer Cells, Natural | 3 | 2005 | 2203 | 0.040 |
Why?
|
Antibodies, Blocking | 3 | 2005 | 242 | 0.040 |
Why?
|
Transplantation Chimera | 2 | 1999 | 595 | 0.040 |
Why?
|
Reperfusion Injury | 1 | 2006 | 1023 | 0.040 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2022 | 277 | 0.040 |
Why?
|
Membrane Glycoproteins | 4 | 2005 | 3707 | 0.040 |
Why?
|
Retroviridae Infections | 1 | 1999 | 146 | 0.040 |
Why?
|
Clone Cells | 1 | 2002 | 1660 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15840 | 0.040 |
Why?
|
Internship and Residency | 1 | 2019 | 5870 | 0.040 |
Why?
|
Lymphocyte Culture Test, Mixed | 4 | 2002 | 516 | 0.040 |
Why?
|
Epitopes | 3 | 1995 | 2503 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2000 | 343 | 0.040 |
Why?
|
Legislation, Medical | 1 | 1998 | 98 | 0.040 |
Why?
|
Aged | 9 | 2024 | 169152 | 0.040 |
Why?
|
Genes | 1 | 1981 | 1845 | 0.040 |
Why?
|
Steroids | 2 | 2000 | 928 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12965 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2001 | 18957 | 0.040 |
Why?
|
Immunoglobulin G | 5 | 2000 | 4541 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2002 | 2116 | 0.040 |
Why?
|
Insulin | 6 | 2008 | 6597 | 0.040 |
Why?
|
Gene Transfer Techniques | 1 | 2002 | 1204 | 0.040 |
Why?
|
Postoperative Care | 1 | 2003 | 1479 | 0.030 |
Why?
|
Portacaval Shunt, Surgical | 1 | 1996 | 46 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 2 | 1998 | 3735 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2005 | 7850 | 0.030 |
Why?
|
Cattle | 1 | 2002 | 3847 | 0.030 |
Why?
|
Hospitals, General | 1 | 2001 | 795 | 0.030 |
Why?
|
Signal Transduction | 5 | 2008 | 23376 | 0.030 |
Why?
|
Genetic Linkage | 1 | 1981 | 2381 | 0.030 |
Why?
|
Kidney Diseases | 2 | 2006 | 2093 | 0.030 |
Why?
|
Solubility | 1 | 1998 | 1088 | 0.030 |
Why?
|
Antigens | 1 | 1981 | 1447 | 0.030 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1998 | 280 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 1998 | 346 | 0.030 |
Why?
|
Models, Animal | 1 | 2002 | 2117 | 0.030 |
Why?
|
Flow Cytometry | 4 | 1996 | 5870 | 0.030 |
Why?
|
Retroviridae | 1 | 1998 | 850 | 0.030 |
Why?
|
Muromonab-CD3 | 2 | 1994 | 104 | 0.030 |
Why?
|
Fibrosis | 1 | 2022 | 2042 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2010 | 8056 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2010 | 791 | 0.030 |
Why?
|
Cell Movement | 1 | 2007 | 5206 | 0.030 |
Why?
|
Tissue Survival | 1 | 1995 | 119 | 0.030 |
Why?
|
Portal Vein | 2 | 2008 | 429 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3529 | 0.030 |
Why?
|
Boston | 3 | 2004 | 9280 | 0.030 |
Why?
|
Clonal Deletion | 1 | 1994 | 74 | 0.030 |
Why?
|
Lymphocyte Subsets | 1 | 1995 | 310 | 0.030 |
Why?
|
Adult | 24 | 2019 | 219994 | 0.030 |
Why?
|
Time Factors | 9 | 2008 | 40165 | 0.030 |
Why?
|
Pancreas | 3 | 2006 | 1677 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2008 | 11481 | 0.030 |
Why?
|
Rodentia | 1 | 1995 | 260 | 0.030 |
Why?
|
Clonal Anergy | 1 | 1994 | 171 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 1981 | 4625 | 0.030 |
Why?
|
Mastectomy, Radical | 2 | 1965 | 19 | 0.030 |
Why?
|
Immunoglobulin M | 3 | 1989 | 1529 | 0.030 |
Why?
|
Hepatitis C | 1 | 2003 | 1579 | 0.030 |
Why?
|
Transplantation, Isogeneic | 2 | 2002 | 248 | 0.030 |
Why?
|
Models, Biological | 2 | 2002 | 9467 | 0.030 |
Why?
|
Pulmonary Embolism | 2 | 2024 | 2543 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2019 | 58995 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2016 | 601 | 0.030 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 1995 | 563 | 0.020 |
Why?
|
Antigen-Antibody Reactions | 2 | 1982 | 346 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2003 | 65017 | 0.020 |
Why?
|
Rats, Inbred WKY | 1 | 1991 | 151 | 0.020 |
Why?
|
Rats, Inbred SHR | 1 | 1991 | 186 | 0.020 |
Why?
|
Glucose Tolerance Test | 2 | 2006 | 1175 | 0.020 |
Why?
|
Haplotypes | 1 | 1998 | 2764 | 0.020 |
Why?
|
Biomedical Research | 1 | 2007 | 3426 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2023 | 8552 | 0.020 |
Why?
|
Cadaver | 4 | 2003 | 1345 | 0.020 |
Why?
|
Inflammation | 2 | 2008 | 10756 | 0.020 |
Why?
|
United States | 5 | 2023 | 72461 | 0.020 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 1993 | 1126 | 0.020 |
Why?
|
Haplorhini | 1 | 1991 | 529 | 0.020 |
Why?
|
Health Planning | 1 | 1992 | 232 | 0.020 |
Why?
|
Life Support Care | 1 | 1992 | 222 | 0.020 |
Why?
|
Ciprofloxacin | 1 | 1992 | 312 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2002 | 2250 | 0.020 |
Why?
|
Federal Government | 1 | 1992 | 267 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2003 | 3061 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2001 | 4357 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1998 | 6131 | 0.020 |
Why?
|
Transfection | 1 | 1998 | 5781 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1989 | 365 | 0.020 |
Why?
|
Sirolimus | 2 | 2007 | 1547 | 0.020 |
Why?
|
Gene Expression | 1 | 2002 | 7588 | 0.020 |
Why?
|
Fluconazole | 1 | 1989 | 155 | 0.020 |
Why?
|
New England | 1 | 1992 | 1050 | 0.020 |
Why?
|
Chemokines | 2 | 2004 | 962 | 0.020 |
Why?
|
Lymphokines | 1 | 1992 | 927 | 0.020 |
Why?
|
Reoperation | 3 | 1996 | 4291 | 0.020 |
Why?
|
Antibody Formation | 2 | 1991 | 1400 | 0.020 |
Why?
|
Autopsy | 2 | 2008 | 1007 | 0.020 |
Why?
|
Urinary Tract Infections | 2 | 1992 | 814 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12531 | 0.020 |
Why?
|
Risk Assessment | 2 | 2024 | 24123 | 0.020 |
Why?
|
Skin | 2 | 1994 | 4466 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2011 | 1130 | 0.020 |
Why?
|
Waiting Lists | 1 | 1992 | 763 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 1992 | 755 | 0.020 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39261 | 0.020 |
Why?
|
Integrin alpha4beta1 | 1 | 2007 | 119 | 0.020 |
Why?
|
Interleukin-15 | 1 | 2007 | 183 | 0.020 |
Why?
|
Blood Glucose | 4 | 2006 | 6381 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22053 | 0.020 |
Why?
|
Kidney Pelvis | 1 | 1987 | 188 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2013 | 2435 | 0.020 |
Why?
|
Mycoses | 1 | 1989 | 387 | 0.020 |
Why?
|
Risk Factors | 4 | 2024 | 74359 | 0.020 |
Why?
|
Creatinine | 4 | 1996 | 1903 | 0.020 |
Why?
|
Binding Sites, Antibody | 2 | 1983 | 337 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5877 | 0.020 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 377 | 0.020 |
Why?
|
Prospective Studies | 4 | 2021 | 54303 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 1992 | 1411 | 0.020 |
Why?
|
Lymph Nodes | 2 | 2008 | 3486 | 0.020 |
Why?
|
Pancreatectomy | 2 | 2006 | 810 | 0.020 |
Why?
|
Cytomegalovirus Infections | 1 | 1992 | 831 | 0.020 |
Why?
|
Sutures | 1 | 1987 | 293 | 0.020 |
Why?
|
Azathioprine | 3 | 1994 | 356 | 0.020 |
Why?
|
Receptors, CXCR3 | 1 | 2006 | 238 | 0.020 |
Why?
|
Lymphocytes | 2 | 1984 | 2611 | 0.020 |
Why?
|
Ureter | 1 | 1987 | 375 | 0.010 |
Why?
|
Hypoglycemic Agents | 2 | 2008 | 3150 | 0.010 |
Why?
|
Chronic Disease | 4 | 2005 | 9287 | 0.010 |
Why?
|
Incidence | 3 | 2013 | 21392 | 0.010 |
Why?
|
Drug Administration Schedule | 2 | 1989 | 4899 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2003 | 7408 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2003 | 5889 | 0.010 |
Why?
|
Young Adult | 3 | 2016 | 58741 | 0.010 |
Why?
|
Binding, Competitive | 2 | 1983 | 1142 | 0.010 |
Why?
|
Insulin Resistance | 2 | 2008 | 3959 | 0.010 |
Why?
|
Mastectomy | 2 | 1965 | 1832 | 0.010 |
Why?
|
Opportunistic Infections | 1 | 2006 | 377 | 0.010 |
Why?
|
L-Selectin | 1 | 2004 | 209 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2008 | 1832 | 0.010 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 1983 | 649 | 0.010 |
Why?
|
Atrophy | 1 | 2008 | 1627 | 0.010 |
Why?
|
Postoperative Period | 1 | 1988 | 1818 | 0.010 |
Why?
|
Biological Therapy | 1 | 2004 | 139 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1989 | 2316 | 0.010 |
Why?
|
Receptors, CCR2 | 1 | 2004 | 215 | 0.010 |
Why?
|
Axilla | 1 | 1965 | 626 | 0.010 |
Why?
|
Length of Stay | 4 | 2003 | 6479 | 0.010 |
Why?
|
Kinetics | 1 | 1990 | 6377 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12159 | 0.010 |
Why?
|
Mice, Nude | 2 | 1993 | 3607 | 0.010 |
Why?
|
Peptides | 2 | 2005 | 4354 | 0.010 |
Why?
|
Mice, Inbred AKR | 1 | 1981 | 104 | 0.010 |
Why?
|
Treatment Failure | 1 | 2008 | 2648 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1992 | 6538 | 0.010 |
Why?
|
Survival Rate | 2 | 1996 | 12808 | 0.010 |
Why?
|
Immunoglobulin Variable Region | 1 | 1983 | 419 | 0.010 |
Why?
|
Cortisone | 1 | 1982 | 87 | 0.010 |
Why?
|
Adolescent | 6 | 2016 | 87810 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2006 | 2234 | 0.010 |
Why?
|
Cohort Studies | 2 | 2015 | 41335 | 0.010 |
Why?
|
Age of Onset | 1 | 2008 | 3301 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7806 | 0.010 |
Why?
|
Cell Fusion | 1 | 1981 | 293 | 0.010 |
Why?
|
Immune Sera | 1 | 2001 | 613 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1982 | 825 | 0.010 |
Why?
|
Ribavirin | 1 | 2003 | 396 | 0.010 |
Why?
|
Diabetic Nephropathies | 1 | 1988 | 988 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2001 | 412 | 0.010 |
Why?
|
Fibrinogen | 1 | 2004 | 886 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2006 | 1630 | 0.010 |
Why?
|
Immunization, Passive | 1 | 1983 | 616 | 0.010 |
Why?
|
STAT4 Transcription Factor | 1 | 2000 | 93 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 2001 | 433 | 0.010 |
Why?
|
Obesity | 1 | 2003 | 12922 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 1993 | 3387 | 0.010 |
Why?
|
Glucagon | 1 | 2002 | 532 | 0.010 |
Why?
|
Probability | 1 | 2006 | 2475 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 1992 | 3143 | 0.010 |
Why?
|
Lymphopenia | 1 | 2002 | 280 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 8035 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2007 | 3094 | 0.010 |
Why?
|
STAT6 Transcription Factor | 1 | 2000 | 193 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3775 | 0.010 |
Why?
|
Cholesterol | 2 | 2004 | 2924 | 0.010 |
Why?
|
Rats | 4 | 1996 | 23711 | 0.010 |
Why?
|
Splenectomy | 1 | 2001 | 391 | 0.010 |
Why?
|
Gastrectomy | 2 | 1957 | 679 | 0.010 |
Why?
|
Transplantation Conditioning | 1 | 2006 | 1588 | 0.010 |
Why?
|
Gene Deletion | 1 | 2007 | 2668 | 0.010 |
Why?
|
Organ Specificity | 1 | 2004 | 1955 | 0.010 |
Why?
|
ABO Blood-Group System | 1 | 2001 | 369 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 1965 | 1303 | 0.010 |
Why?
|
Retreatment | 1 | 2000 | 600 | 0.010 |
Why?
|
Age Factors | 2 | 1994 | 18416 | 0.010 |
Why?
|
Lymphoproliferative Disorders | 1 | 2002 | 533 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4573 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4925 | 0.010 |
Why?
|
Interferon-alpha | 1 | 2003 | 918 | 0.010 |
Why?
|
Complement System Proteins | 1 | 1981 | 782 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2004 | 15757 | 0.010 |
Why?
|
Blood Proteins | 1 | 2003 | 1173 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2003 | 1135 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 1965 | 2943 | 0.010 |
Why?
|
Prednisone | 2 | 1994 | 1565 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2006 | 6238 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2001 | 2536 | 0.010 |
Why?
|
Constriction | 1 | 1996 | 172 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 1996 | 374 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1992 | 4319 | 0.010 |
Why?
|
RNA | 1 | 2006 | 2722 | 0.010 |
Why?
|
Phenotype | 2 | 1993 | 16546 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4122 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2006 | 5201 | 0.010 |
Why?
|
Cell Separation | 1 | 2001 | 1720 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 1996 | 436 | 0.010 |
Why?
|
Thrombophlebitis | 1 | 1996 | 288 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2006 | 18137 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2003 | 3157 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2004 | 2420 | 0.010 |
Why?
|
Medicare | 1 | 1992 | 6786 | 0.010 |
Why?
|
Monitoring, Immunologic | 1 | 1993 | 98 | 0.010 |
Why?
|
Vena Cava, Inferior | 1 | 1996 | 458 | 0.010 |
Why?
|
Pentamidine | 1 | 1992 | 44 | 0.010 |
Why?
|
H-Y Antigen | 1 | 1992 | 42 | 0.010 |
Why?
|
Adenoma, Bile Duct | 1 | 1992 | 29 | 0.010 |
Why?
|
Peptic Ulcer Perforation | 1 | 1952 | 22 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11071 | 0.010 |
Why?
|
Chimera | 1 | 1993 | 453 | 0.010 |
Why?
|
Immunoglobulin Isotypes | 1 | 1992 | 158 | 0.010 |
Why?
|
Recurrence | 1 | 2004 | 8482 | 0.010 |
Why?
|
Survival | 1 | 1992 | 161 | 0.010 |
Why?
|
Erythrocyte Transfusion | 1 | 1996 | 566 | 0.010 |
Why?
|
Glucose | 1 | 2003 | 4351 | 0.010 |
Why?
|
Biopsy | 1 | 2003 | 6771 | 0.010 |
Why?
|
Antibody Specificity | 2 | 1983 | 1060 | 0.010 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1992 | 245 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14660 | 0.010 |
Why?
|
Trans-Activators | 1 | 2000 | 2860 | 0.010 |
Why?
|
Blood Group Antigens | 1 | 1991 | 187 | 0.010 |
Why?
|
Drug Therapy, Combination | 2 | 1992 | 6498 | 0.010 |
Why?
|
Aerosols | 1 | 1992 | 632 | 0.010 |
Why?
|
Immunization | 1 | 1994 | 1227 | 0.010 |
Why?
|
Quality of Life | 1 | 1991 | 13308 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 1998 | 2180 | 0.010 |
Why?
|
Child, Preschool | 1 | 1992 | 42063 | 0.010 |
Why?
|
Cryptococcus neoformans | 1 | 1989 | 121 | 0.000 |
Why?
|
Candida | 1 | 1989 | 173 | 0.000 |
Why?
|
Laparoscopy | 1 | 2001 | 2147 | 0.000 |
Why?
|
HLA Antigens | 1 | 1994 | 1368 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2006 | 20080 | 0.000 |
Why?
|
Drug Resistance | 1 | 1994 | 1617 | 0.000 |
Why?
|
Survival Analysis | 1 | 2000 | 10182 | 0.000 |
Why?
|
Child | 2 | 1994 | 79806 | 0.000 |
Why?
|
Mice, Inbred DBA | 1 | 1988 | 622 | 0.000 |
Why?
|
Liver | 1 | 2003 | 7509 | 0.000 |
Why?
|
Evaluation Studies as Topic | 1 | 1989 | 1628 | 0.000 |
Why?
|
Isoenzymes | 1 | 1991 | 1690 | 0.000 |
Why?
|
Renal Dialysis | 1 | 1996 | 1801 | 0.000 |
Why?
|
Ureteral Calculi | 1 | 1987 | 116 | 0.000 |
Why?
|
Methylprednisolone | 1 | 1987 | 384 | 0.000 |
Why?
|
Duodenum | 1 | 1989 | 486 | 0.000 |
Why?
|
Hepatectomy | 1 | 1989 | 559 | 0.000 |
Why?
|
Bone Marrow Cells | 1 | 1993 | 2414 | 0.000 |
Why?
|
Costs and Cost Analysis | 1 | 1990 | 1677 | 0.000 |
Why?
|
Triglycerides | 1 | 1991 | 2476 | 0.000 |
Why?
|
Random Allocation | 1 | 1987 | 2394 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 9585 | 0.000 |
Why?
|
Vascular Diseases | 1 | 1991 | 1182 | 0.000 |
Why?
|
Breast | 1 | 1951 | 1963 | 0.000 |
Why?
|
Stroke Volume | 1 | 1996 | 5523 | 0.000 |
Why?
|
Immunoglobulin Light Chains | 1 | 1982 | 286 | 0.000 |
Why?
|
Fibroblasts | 1 | 1992 | 4090 | 0.000 |
Why?
|
Cross Reactions | 1 | 1983 | 818 | 0.000 |
Why?
|
Blood Pressure | 1 | 1996 | 8525 | 0.000 |
Why?
|
Macromolecular Substances | 1 | 1982 | 1433 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1958 | 9276 | 0.000 |
Why?
|
Patient Readmission | 1 | 1994 | 3323 | 0.000 |
Why?
|
Risk | 1 | 1992 | 9631 | 0.000 |
Why?
|
Administration, Oral | 1 | 1987 | 4035 | 0.000 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1992 | 2299 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1992 | 12427 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 1965 | 21025 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1990 | 10827 | 0.000 |
Why?
|
Longevity | 1 | 1984 | 1050 | 0.000 |
Why?
|
Brain | 1 | 1982 | 26951 | 0.000 |
Why?
|
Pilot Projects | 1 | 1988 | 8555 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1990 | 10344 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1982 | 13451 | 0.000 |
Why?
|
Hypertension | 1 | 1990 | 8594 | 0.000 |
Why?
|